These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17038469)

  • 1. The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity.
    Cancro MP
    Ann Rheum Dis; 2006 Nov; 65 Suppl 3(Suppl 3):iii34-6. PubMed ID: 17038469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The late news on baff in autoimmune diseases.
    Youinou P; Pers JO
    Autoimmun Rev; 2010 Oct; 9(12):804-6. PubMed ID: 20656068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production.
    Kalled SL
    Semin Immunol; 2006 Oct; 18(5):290-6. PubMed ID: 16931038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAFF, APRIL and their receptors: structure, function and signaling.
    Bossen C; Schneider P
    Semin Immunol; 2006 Oct; 18(5):263-75. PubMed ID: 16914324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BLyS receptor signatures resolve homeostatically independent compartments among naïve and antigen-experienced B cells.
    Treml LS; Crowley JE; Cancro MP
    Semin Immunol; 2006 Oct; 18(5):297-304. PubMed ID: 16919470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of B cell self-tolerance by BAFF.
    Brink R
    Semin Immunol; 2006 Oct; 18(5):276-83. PubMed ID: 16916609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAFF, APRIL and human B cell disorders.
    Tangye SG; Bryant VL; Cuss AK; Good KL
    Semin Immunol; 2006 Oct; 18(5):305-17. PubMed ID: 16916610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BLyS and B cell homeostasis.
    Woodland RT; Schmidt MR; Thompson CB
    Semin Immunol; 2006 Oct; 18(5):318-26. PubMed ID: 16931037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of APRIL and BAFF in lymphocyte activation.
    Schneider P
    Curr Opin Immunol; 2005 Jun; 17(3):282-9. PubMed ID: 15886118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?
    Binard A; Le Pottier L; Saraux A; Devauchelle-Pensec V; Pers JO; Youinou P
    J Autoimmun; 2008; 30(1-2):63-7. PubMed ID: 18155417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis.
    Zhang M; Ko KH; Lam QL; Lo CK; Srivastava G; Zheng B; Lau YL; Lu L
    Int Immunol; 2005 Aug; 17(8):1081-92. PubMed ID: 16000326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the BAFF/APRIL system on T cell function.
    Mackay F; Leung H
    Semin Immunol; 2006 Oct; 18(5):284-9. PubMed ID: 16931039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors.
    Kreuzaler M; Rauch M; Salzer U; Birmelin J; Rizzi M; Grimbacher B; Plebani A; Lougaris V; Quinti I; Thon V; Litzman J; Schlesier M; Warnatz K; Thiel J; Rolink AG; Eibel H
    J Immunol; 2012 Jan; 188(1):497-503. PubMed ID: 22124120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
    Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
    Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF).
    Sène D; Limal N; Ghillani-Dalbin P; Saadoun D; Piette JC; Cacoub P
    Rheumatology (Oxford); 2007 Jan; 46(1):65-9. PubMed ID: 16782735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling.
    Mackay F; Silveira PA; Brink R
    Curr Opin Immunol; 2007 Jun; 19(3):327-36. PubMed ID: 17433868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAFF-targeting therapy, a promising strategy for treating autoimmune diseases.
    Sun J; Lin Z; Feng J; Li Y; Shen B
    Eur J Pharmacol; 2008 Nov; 597(1-3):1-5. PubMed ID: 18793632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas.
    Sutherland AP; Mackay F; Mackay CR
    Pharmacol Ther; 2006 Dec; 112(3):774-86. PubMed ID: 16863659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An APRIL to remember: novel TNF ligands as therapeutic targets.
    Dillon SR; Gross JA; Ansell SM; Novak AJ
    Nat Rev Drug Discov; 2006 Mar; 5(3):235-46. PubMed ID: 16474316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity.
    Krumbholz M; Faber H; Steinmeyer F; Hoffmann LA; Kümpfel T; Pellkofer H; Derfuss T; Ionescu C; Starck M; Hafner C; Hohlfeld R; Meinl E
    Brain; 2008 Jun; 131(Pt 6):1455-63. PubMed ID: 18474519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.